High-Dose Albumin for Neuroprotection in Acute Ischemic Stroke: From Basic Investigations to Multicenter Clinical Trial
Author:
Ginsberg Myron D.
Publisher
Springer New York
Reference95 articles.
1. Alexander MR, Ambre JJ, Liskow BI, Trost DC. Therapeutic use of albumin. JAMA. 1979;241:2527–9.
2. Ammit AJ, O’Neill C. Studies of the nature of the binding by albumin of platelet-activating factor released from cells. J Biol Chem. 1997;272:18772–8.
3. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev. 2002;(4):CD000103.
4. Back T, Zhao W, Ginsberg MD. Three-dimensional image analysis of brain glucose metabolism-blood flow uncoupling and its electrophysiological correlates in the acute ischemic penumbra following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1995;15:566–77.
5. Bar-Or D, Rael LT, Lau EP, Rao NK, Thomas GW, Winkler JV, Yukl RL, Kingston RG, Curtis CG. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun. 2001;284:856–62.